“The relationship between IPRs and biopharmaceutical innovation is together with copyright on the internet perhaps the most contentiously debated topic in the literature.” ~ “Taking Stock: the Gains of Global Biotechnology Research from IPRs” Proponents argue that IPRs are essential to pharmaceutical and biotechnological innovation and provide innovators with the necessary incentives to continue to […]

The United States along with Australia, Canada, the European Union and its member states, Japan, South Korea, Mexico, Morocco, New Zealand, Singapore, and Switzerland reaffirmed their commitment to the Anti-Counterfeiting Trade Agreement (ACTA) at a signing ceremony in Tokyo. The agreement is meant to fight against the infringement of intellectual property rights (IPR), in particular […]